Kolon Life Science Inc. (KOSDAQ:102940)
South Korea flag South Korea · Delayed Price · Currency is KRW
65,300
+1,300 (2.03%)
Feb 9, 2026, 10:52 AM KST

Kolon Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
7,56712,4987,5616,37127,80015,001
Short-Term Investments
----11030
Cash & Short-Term Investments
7,56712,4987,5616,37127,91015,031
Cash Growth
-42.95%65.29%18.68%-77.17%85.69%-28.13%
Accounts Receivable
36,75136,69924,60529,44019,64922,199
Other Receivables
239.421,0941,008302.04638.16398.12
Receivables
36,99137,79425,61329,74220,28722,597
Inventory
52,83346,72667,77768,49445,99842,790
Prepaid Expenses
3,7324,1273,4064,5793,7437,237
Other Current Assets
734.54909.02688.31998.1682.5712,908
Total Current Assets
101,858102,055105,045110,18498,021100,563
Property, Plant & Equipment
131,750115,076123,138125,960131,481141,893
Long-Term Investments
402,751197,22377,05475,2402,5493,262
Goodwill
---1,2171,2171,217
Other Intangible Assets
1,087554.34168.2858.9599.11199.79
Long-Term Accounts Receivable
0-00-0-0-0
Long-Term Deferred Charges
644.86164.25283.64403.04522.43
Other Long-Term Assets
4,6844,6103,8661,174888.54680.57
Total Assets
642,136419,563309,436314,118234,658248,338
Accounts Payable
12,97411,9507,44217,04913,77411,808
Accrued Expenses
4,2804,9084,3553,5943,1452,721
Short-Term Debt
100,709105,89097,26269,46159,06461,751
Current Portion of Long-Term Debt
4,9949,993-4,0005,3335,333
Current Portion of Leases
713.36692.76428.66287.62336.45348.65
Current Income Taxes Payable
51.72--376.36--
Current Unearned Revenue
3,2013,2013,2013,2013,5003,500
Other Current Liabilities
56,20269,62015,65311,60810,31659,689
Total Current Liabilities
183,125206,255128,341109,57895,469145,152
Long-Term Debt
14,8608,6999,980-4,0009,333
Long-Term Leases
1,0901,324191.33167.18191.02262.15
Pension & Post-Retirement Benefits
6,1916,8316,4399,81210,4499,730
Long-Term Deferred Tax Liabilities
76,50333,6299,8749,760--
Other Long-Term Liabilities
13,95413,48716,93817,07825,13925,903
Total Liabilities
295,724270,225171,764146,395135,248190,381
Common Stock
6,2126,2125,7065,7065,7065,706
Additional Paid-In Capital
192,801192,801167,553209,114209,542167,980
Retained Earnings
-193,671-228,091-133,289-101,537-106,024-104,359
Treasury Stock
-----812.88-812.88
Comprehensive Income & Other
341,071178,41797,70254,440-9,001-10,557
Total Common Equity
346,412149,338137,672167,72399,41057,957
Shareholders' Equity
346,412149,338137,672167,72399,41057,957
Total Liabilities & Equity
642,136419,563309,436314,118234,658248,338
Total Debt
122,366126,598107,86373,91668,92577,029
Net Cash (Debt)
-114,799-114,100-100,301-67,545-41,015-61,998
Net Cash Per Share
-8323.10-9553.71-8788.83-5344.94-3597.74-5438.33
Filing Date Shares Outstanding
12.4212.4211.4111.4111.411.4
Total Common Shares Outstanding
12.4212.4211.4111.4111.411.4
Working Capital
-81,268-104,200-23,296606.752,552-44,589
Book Value Per Share
27883.8612020.6812063.4114696.648720.065083.88
Tangible Book Value
345,325148,783137,504166,44898,09456,541
Tangible Book Value Per Share
27796.3811976.0512048.6714584.868604.644959.63
Land
16,25816,28116,28117,28617,00817,024
Buildings
64,18981,46288,06988,56788,89188,874
Machinery
33,746108,063104,638101,589102,95290,469
Construction In Progress
15,77413,85717,81016,47415,95228,846
Source: S&P Global Market Intelligence. Standard template. Financial Sources.